Prevalence and Predictors of Multi-Drug Resistant Organisms Among Ambulatory Cancer Patients with Urinary Tract Infections.
Aseel K AbuSaraNabiha TayyebLujain MatalkaBayan AlmomaniHaneen AbazaLama NazerPublished in: Infection and drug resistance (2023)
More than half of the positive urine cultures of cancer patients treated for UTIs in the ambulatory setting were MDROs. A subsequent UTI due to MDROs is more likely to occur in patients who had a UTI with an MDRO within the past 6 months.